Articles Tagged With: mammography
-
Do We Overdiagnose Breast Cancer in Women 70 Years and Older?
Overdiagnosis of breast cancer from mammography is common in women age 70 years and older and increases with age. The use of mammography in women older than age 70 years does not reduce breast cancer deaths.
-
Breast Cancer Screening: Tomosynthesis Is Beneficial for High-Risk Patients
This cohort study examined rates of advanced breast cancer diagnosis among women screened with digital mammography and digital breast tomosynthesis (DBT). Women with extremely dense breasts and who were at high risk for breast cancer benefited from DBT, with a 53% lower risk of developing advanced cancer compared to those screened with digital mammography alone. No differences were seen for women at low to average risk.
-
Breast MRI Exams Increase the Biopsy Rate Without Improving Cancer Detection
Compared to women who undergo breast cancer screening with mammography alone, those receiving MRI exams experience a two- to fivefold increased rate of core and surgical biopsy. However, the biopsies have a lower cancer yield rate than mammography alone.
-
2016 USPSTF Update: Harms and Supplemental Screening
The decision to undergo screening mammography requires a consideration of benefits and harms. Harms include false-positive exams leading to unnecessary interventions, and true-positive exams that lead to overdiagnosis.
-
U.S. Preventive Services Task Force issues new breast cancer screening guidance
The U.S. Preventive Services Task Force has issued new guidance on breast cancer screening and called for mammography every two years for women ages 50-74. For women ages 40-49, the Task Force recommends informed, individualized decision-making based on a woman’s values, preferences, and health history.
-
2016 USPSTF Update: Recommendations for and Effectiveness of Screening Mammography
The U.S. Preventive Services Task Force recently released updates to the 2009 recommendations on breast cancer screening. Additional studies published since the last review strengthen the conclusion that mammography screening results in a reduction in the risk of death from breast cancer.
-
Ultrasound for Dense Breasts — Is It Worth the Cost?
A cost-effectiveness model found that supplemental ultrasound screening after a negative mammogram for women with dense breasts substantially increases costs without yielding significant benefit.
-
Mammography and the Overdiagnosis of Breast Cancer: What to Do?
A new study reports that the incidence of breast cancer is higher in counties with high rates of mammography screening, but screening is not associated with a decrease in breast-cancer deaths. The decision of whether and how often to perform mammography requires a discussion of the potential consequences of both true positive and false positive screening tests.
-
Mammograms: The Cost of Overdiagnosis
In the United States, the costs associated with the management of false-positive mammograms and breast cancer overdiagnosis is estimated to be $4 billion each year.